Utama › Penyakit Paru Interstisial
Kajian klinikal Penyakit Paru Interstisial sedang mengambil peserta di AS
53 kajian untuk Penyakit Paru Interstisial sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY18 kajian
- Philadelphia, PA16 kajian
- Los Angeles, CA14 kajian
- Kansas City, KS13 kajian
- Durham, NC13 kajian
- Charleston, SC13 kajian
- Chicago, IL12 kajian
- Houston, TX12 kajian
- Ann Arbor, MI11 kajian
- Aurora, CO11 kajian
- Phoenix, AZ9 kajian
- Salt Lake City, UT9 kajian
- Boston, MA9 kajian
- Rochester, MN9 kajian
- Birmingham, AL9 kajian
- Dallas, TX9 kajian
- Orlando, FL9 kajian
- Cincinnati, OH8 kajian
- Tampa, FL8 kajian
- Minneapolis, MN8 kajian
- San Francisco, CA7 kajian
- Bend, OR7 kajian
- Richmond, VA6 kajian
- Washington, DC6 kajian
- Denver, CO6 kajian
- Indianapolis, IN6 kajian
- Naples, FL5 kajian
- Gainesville, FL5 kajian
- Jacksonville, FL5 kajian
- Columbus, OH5 kajian
- Oklahoma City, OK5 kajian
- Winston-Salem, NC5 kajian
- Cleveland, OH5 kajian
- Albuquerque, NM5 kajian
- Nashville, TN5 kajian
- Pittsburgh, PA5 kajian
- Scottsdale, AZ4 kajian
- New Haven, CT4 kajian
- Rochester, NY4 kajian
- New Orleans, LA4 kajian
Mengikut negeri
- Alabama9 kajian
- Arizona13 kajian
- California22 kajian
- Colorado15 kajian
- Connecticut4 kajian
- Florida24 kajian
- Georgia3 kajian
- Illinois12 kajian
- Indiana6 kajian
- Kansas13 kajian
- Kentucky4 kajian
- Louisiana5 kajian
- Maryland5 kajian
- Massachusetts11 kajian
- Michigan16 kajian
- Minnesota14 kajian
- Mississippi3 kajian
- Missouri6 kajian
- Nevada4 kajian
- New Jersey3 kajian
- New Mexico5 kajian
- New York20 kajian
- North Carolina18 kajian
- Ohio14 kajian
- Oklahoma5 kajian
- Oregon9 kajian
- Pennsylvania18 kajian
- South Carolina14 kajian
- Tennessee7 kajian
- Texas18 kajian
- Utah9 kajian
- Virginia8 kajian
- Wilayah Columbia5 kajian
- Wisconsin4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05798923Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07613099Pulmonary Fibrosis Foundation Community Registry
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT05382572A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07323732A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07816185SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07269262A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Mengambil pesertaFasa 2
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07333183Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT00258583DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07486869PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06855329Platform Clinical Study for Conquering Scleroderma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Mengambil pesertaFasa 2/3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06328777Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Mengambil pesertaFasa 2
Umur 8 hingga 60 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT03630211An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Ogo 2026 · NCT07234032Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.